Literature DB >> 24984291

Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.

Diwesh Chawla1, Savita Bansal2, Basu Dev Banerjee3, Sri Venkata Madhu4, Om Prakash Kalra5, Ashok Kumar Tripathi6.   

Abstract

AIMS: Vascular complications are the major causes of morbidity and mortality in diabetic subjects. Interaction of advanced glycation end products (AGEs) with their receptor (RAGE) induces signal transduction that culminates in vascular complications. Therefore, in the present study we investigated the dependence of RAGE expression on circulating AGEs and evaluated the outcome of AGE-RAGE interaction by the oxidative stress and nature of vascular complications in type 2 diabetes mellitus (T2DM) patients.
METHODS: RAGE expression was determined by quantitative real-time PCR and western blotting, serum AGEs were estimated by ELISA and spectrofluorometry and oxidative stress markers namely protein carbonyl (PCO), advanced oxidation protein products (AOPP) and lipid peroxidation (MDA) were assayed spectrophotometerically in 75 T2DM patients (DM without vascular complication n=25; DM with microvascular complications n=25; DM with macrovascular complications n=25) and 25 healthy controls.
RESULTS: Serum AGE level was significantly higher in diabetic patients having vascular complications as compared to T2DM without complications (p<0.01). RAGE m-RNA expression level in PBMCs assayed by quantitative real time PCR was four times higher in diabetic subjects without vascular complications while DM patients having microvascular and macrovascular complications showed 12 fold and 8 fold higher RAGE m-RNA expression respectively compared to healthy controls. Circulating AGE level showed significant positive correlation with RAGE m-RNA expression and oxidative stress markers.
CONCLUSION: AGE-mediated exacerbation of RAGE expression may contribute to oxidative stress generation that plays a key role in pathogenesis of vascular complications in diabetes.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Advanced glycation end products; Oxidative stress; RAGE expression; Type 2 diabetes mellitus; Vascular complication

Mesh:

Substances:

Year:  2014        PMID: 24984291     DOI: 10.1016/j.mvr.2014.06.010

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  20 in total

Review 1.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

2.  Factors Generating Glucose Degradation Products In Sterile Glucose Solutions For Infusion: Statistical Relevance Determination Of Their Impacts.

Authors:  J Haybrard; N Simon; C Danel; C Pinçon; C Barthélémy; F J Tessier; B Décaudin; E Boulanger; P Odou
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

3.  Advanced glycation end-products induce apoptosis in pancreatic islet endothelial cells via NF-κB-activated cyclooxygenase-2/prostaglandin E2 up-regulation.

Authors:  Kuo-Cheng Lan; Chen-Yuan Chiu; Chia-Wei Kao; Kuo-How Huang; Ching-Chia Wang; Kuo-Tong Huang; Keh-Sung Tsai; Meei-Ling Sheu; Shing Hwa Liu
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

4.  Effects of methanolic extracts from edible plants on endogenous secretory receptor for advanced glycation end products induced by the high glucose incubation in human endothelial cells.

Authors:  Yoshinori Okada; Mizue Okada
Journal:  J Pharm Bioallied Sci       Date:  2015 Apr-Jun

5.  Sevelamer reduces endothelial inflammatory response to advanced glycation end products.

Authors:  Paulo C Gregório; Giane Favretto; Guilherme L Sassaki; Regiane S Cunha; Alessandra Becker-Finco; Roberto Pecoits-Filho; Wesley M Souza; Fellype C Barreto; Andréa E M Stinghen
Journal:  Clin Kidney J       Date:  2017-09-05

6.  Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy.

Authors:  Bin Zhang; Qiang Shen; Yaping Chen; Ruile Pan; Shihuan Kuang; Guiyan Liu; Guibo Sun; Xiaobo Sun
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

7.  Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance.

Authors:  Bahar Saberzadeh-Ardestani; Razieh Karamzadeh; Mohsen Basiri; Ensiyeh Hajizadeh-Saffar; Aisan Farhadi; A M J Shapiro; Yaser Tahamtani; Hossein Baharvand
Journal:  Cell J       Date:  2018-05-15       Impact factor: 2.479

8.  [Association of plasma level of advanced oxidation protein products with Framingham risk score in type 2 diabetic patients without vascular diseases].

Authors:  Chao Xie; Jie Tian; Wei Li; Min Liang; Yao-Zhong Kong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

9.  Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats.

Authors:  Amporn Jariyapongskul; Chonticha Areebambud; Sunit Suksamrarn; Chantana Mekseepralard
Journal:  Biomed Res Int       Date:  2015-04-09       Impact factor: 3.411

10.  Inhibitory Effect of Bunium Persicum Hydroalcoholic Extract on Glucose-Induced Albumin Glycation, Oxidation, and Aggregation In Vitro.

Authors:  Arman Seri; Marjan Khorsand; Zahra Rezaei; Azadeh Hamedi; Mohammad Ali Takhshid
Journal:  Iran J Med Sci       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.